Echo Therapeutics (ECTE) 0.74 $ECTE
Platinum Comments On Recent Statements Purportedly Made By Echo Therapeutics
PR Newswire - Mon Oct 06, 8:26AM CDT
An affiliate of Platinum Management (NY) LLC ("Platinum"
, the largest stockholder of Echo Therapeutics, Inc. ("Echo" or the "Company" (NASDAQ: ECTE) owning approximately 30% of Echo's outstanding Common Stock on a fully converted basis, today commented on recent statements made, Platinum can only assume, by William Grieco, Vincent Enright and James Smith (the "Lingering Directors" , purportedly on behalf of Echo.
ECTE: 0.74 (+0.03)
Echo Therapeutics Comments On Special Meeting Proxy Contest Threatened By Platinum Management (NY) LLC
PR Newswire - Mon Oct 06, 8:10AM CDT
Echo Therapeutics, Inc. (NASDAQ: ECTE), a medical device company, today commented on the special meeting proxy contest that has been recently threatened by Platinum Management (NY) LLC and its affiliates in their latest attempt to force off the Echo Board the only independent board members that were not designated or nominated by Platinum.
ECTE: 0.74 (+0.03)
Echo Therapeutics Engages PricewaterhouseCoopers' Restructuring Practice to Explore Financial and Strategic Alternatives
PR Newswire - Thu Oct 02, 3:59PM CDT
Echo Therapeutics, Inc. (NASDAQ: ECTE), a medical device company, today announced that the Company has retained PricewaterhouseCoopers LLP's Restructuring and Recovery Services Practice (PwC) as a financial and restructuring consultant to assist the Company in exploring financial and strategic alternatives that could sufficiently address its liquidity needs and allow it to resume operations. Such financial and strategic alternatives could include, but are not limited to, a sale of intellectual property and other assets, a merger, other business combination, a capital transaction and/or a voluntary petition for reorganization or liquidation pursuant to the U.S. Bankruptcy Code.
ECTE: 0.74 (+0.03)
Echo Therapeutics Comments On Unauthorized Public Statements By Michael M. Goldberg, M.D. And Shepard M. Goldberg
PR Newswire - Thu Oct 02, 6:50AM CDT
Echo Therapeutics, Inc. (NASDAQ: ECTE), a medical device company, today commented on the recent unauthorized public statements relating to Echo that have been made by Michael Goldberg M.D. and Shepard M. Goldberg, two members of the Echo Board of Directors that were either designated or nominated to the Echo Board by an affiliate of Platinum Management (NY) LLC. In recent weeks, the Goldbergs have engaged in numerous unauthorized public communications targeted at Echo stockholders, the trading markets and the media. These have included an unauthorized public "investor" conference call during which the Goldbergs made a presentation relating to Echo, unauthorized press releases discussing Echo and other unauthorized statements by which the Goldbergs have sought to relay to Echo stockholders information relating to Echo, its prospects and its financing and strategic alternatives.
ECTE: 0.74 (+0.03)
Echo Therapeutics Suspends Operations on Cash Concerns - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 29, 4:45PM CDT
Following the company's decision, shares of Echo Therapeutics, Inc. (ECTE) crashed a substantial 32.5% to finally close at $0.77 till the last trading session.
ECTE: 0.74 (+0.03), ATEC: 1.49 (unch), EW: 105.81 (+3.94), ERB: 2.76 (-0.01)
Platinum Management (NY) LLC Calls for a Special Meeting of Stockholders at Echo Therapeutics, Inc.
PR Newswire - Mon Sep 29, 2:49PM CDT
Platinum Management (NY) LLC ("Platinum" , the largest stockholder of Echo Therapeutics, Inc. ("Echo" or the "Company" (NASDAQ: ECTE) together with its affiliates owning approximately 30% of Echo's outstanding Common Stock on a fully converted basis, today announced that it intends to file the documents required to demand a Special Meeting of stockholders of Echo to remove, for cause, Directors William Grieco, Vincent Enright and James Smith. (collectively, the "Lingering Directors"
ECTE: 0.74 (+0.03)
Platinum Management and Newly Elected Board Members Unveil New Financing Plan for Echo Therapeutics
GlobeNewswire - Wed Sep 24, 8:21AM CDT
Michael Goldberg M.D. and Shepard M. Goldberg, both recently elected board members of Echo Therapeutics (Nasdaq:ECTE), have expressed alarm at the press release issued by the Company yesterday evening, September 23. Dr. Goldberg and Mr. Goldberg believe the release, which they had not seen prior to its publication, contains numerous errors, misstatements and is not an accurate reflection of the current state of affairs at Echo Therapeutics. In fact, Dr. Goldberg and Mr. Goldberg, in an effort to salvage the company, have negotiated a financing deal that meets and exceeds the terms stated as necessary in the release issued by the opposing members of Echo's board. The proposed plan will allow Echo to continue operations and to reach key valuation events prior to requiring additional capital. The plan set forth by Dr. and Mr. Goldberg has the added benefit of having the support of Echo's former key technical staff members who were terminated yesterday but who remain committed to the company.
ECTE: 0.74 (+0.03)
Market Maker Surveillance Report. RITT, JRJC, UQM, GLMD, SINO, ECTE, Winning Stocks With Lowest Price Friction For Tuesday, September 23rd 2014
M2 - Wed Sep 24, 3:42AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 4582 companies with "abnormal" market making, 1424 companies with positive Friction Factors and 3854 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Tuesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Rit Technologies Ltd (NASDAQ:RITT), China Finance Online Co Ltd (NASDAQ:JRJC), UQM Technologies Inc (NYSE:UQM), GOLD MEDAL RES LTD (NASDAQ:GLMD), Sino-Global Shipping America Ltd (NASDAQ:SINO), Echo Therapeutics Inc (NASDAQ:ECTE). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
ECTE: 0.74 (+0.03), JRJC: 5.45 (+0.08), GLMD: 6.49 (-0.27), UQM: 1.09 (+0.01), RITT: 1.21 (+0.06), SINO: 2.04 (+0.31)
Echo Therapeutics Suspends Operations To Conserve Liquidity
PR Newswire - Tue Sep 23, 5:40PM CDT
Echo Therapeutics, Inc. (NASDAQ: ECTE), a medical device company, today announced that, as it believes that its current liquidity is insufficient to fund its needs beyond September 30, 2014, it has suspended its product development, research, manufacturing and clinical programs and operations to conserve its liquidity and capital resources.
ECTE: 0.74 (+0.03)
Market Maker Surveillance Report. CNQR, CNET, MGPI, INUV, ECTE, DSLV, Winning Stocks With Lowest Price Friction For Friday, September 19th 2014
M2 - Mon Sep 22, 3:07AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Friday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Friday there were 4914 companies with "abnormal" market making, 1880 companies with positive Friction Factors and 3143 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Friday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Concur Technologies Inc (NASDAQ:CNQR), Chinanet Online Holdings Inc (NASDAQ:CNET), MGP Ingredients Inc (NASDAQ:MGPI), Inuvo Inc (NYSE:INUV), Echo Therapeutics Inc (NASDAQ:ECTE), (NYSE
SLV). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
ECTE: 0.74 (+0.03), CNQR: 127.86 (+0.02), INUV: 1.39 (+0.12), MGPI: 12.24 (+0.24), DSLV: 62.04 (-0.80), CNET: 2.05 (+0.22)
Newly Elected Board Members of Echo Therapeutics to Host Conference Call to Provide Shareholder Update on Monday, September 22nd
GlobeNewswire - Fri Sep 19, 3:25PM CDT
Michael Goldberg M.D. and Shepard M. Goldberg, both recently elected board members of Echo Therapeutics (Nasdaq:ECTE), will host a conference call with investors to discuss recent developments and also their goals to establish a new strategic direction for the company which will require the removal of the three predecessor directors for cause. In light of recent events at Echo Therapeutics, Dr. Goldberg and Mr. Goldberg have been contacted by a number of shareholders regarding their concerns about the stock price and lack of information from the current management team.
ECTE: 0.74 (+0.03)
Platinum to refund USD5m investment in Echo Therapeutics
M2 - Thu Sep 18, 7:15AM CDT
Platinum Wednesday disclosed its intention on Wednesday to seek the return of its USD5m investment in Echo in connection with the 10 December 2013 Securities Purchase Agreement.
ECTE: 0.74 (+0.03)
Platinum Seeks Return Of $5 Million Investment In Echo Therapeutics
PR Newswire - Wed Sep 17, 4:07PM CDT
Platinum Management (NY) LLC ("Platinum" , the largest stockholder of Echo Therapeutics, Inc. ("Echo" or the "Company" (NASDAQ: ECTE) together with its affiliates owning approximately 30% of Echo's outstanding Common Stock on a fully converted basis, today delivered a letter to the members of the Echo Board of Directors disclosing its intention to seek the return of their $5 million investment in Echo in connection with the December 10, 2013 Securities Purchase Agreement. Platinum believes that Echo entered into the contract in bad faith with no intention of performing its obligations or using the funds for the intended purposes. Investors wishing to read the full letter are welcome to review Platinum's 13D, which attaches the full letter as an exhibit. Platinum's 13D may be found here: http://www.sec.gov/Archives/edgar/data/103192...091714.htm
ECTE: 0.74 (+0.03)
Alphatec Holdings (ATEC) Worth Watching: Stock Adds 7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Sep 17, 8:46AM CDT
Alphatec Holdings (ATEC) was a big mover last session, with shares rising just over 7% on the day.
ECTE: 0.74 (+0.03), ATEC: 1.49 (unch), BONE: 4.28 (+0.20), RTIX: 3.64 (+0.03)
Sunshine Heart (SSH) Worth Watching: Stock Gains 8.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Sep 17, 8:25AM CDT
Sunshine Heart (SSH) was a big mover last session, with shares rising over 8% on the day.
ECTE: 0.74 (+0.03), SSH: 5.29 (+0.03), BONE: 4.28 (+0.20), RTIX: 3.64 (+0.03)
Echo Therapeutics Board Once Again Impedes The Rights Of Echo Stockholders
PR Newswire - Fri Sep 12, 4:53PM CDT
An affiliate of Platinum Management (NY) LLC ("Platinum" , the largest stockholder of Echo Therapeutics, Inc. ("Echo" or the "Company" (NASDAQ: ECTE) owning approximately 30% of Echo's outstanding Common Stock on a fully converted basis, today filed suit in Delaware following the refusal by Echo to provide documents in response to Platinum's demand for certain books and records of the Company under Section 220 of the Delaware General Corporation Law. Platinum had previously delivered a letter to Echo pursuant to Section 220 demanding to inspect books and records relating to possible mismanagement, breaches of fiduciary duty and wrongdoing by, among others, members of the Board and the Company's current interim CEO, Kimberly A. Burke.
ECTE: 0.74 (+0.03)
IRadimed (IRMD) Jumps: Stock Moves 7.4% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Sep 05, 8:25AM CDT
IRadimed (IRMD) was a big mover last session, with shares rising over 7% on the day.
ECTE: 0.74 (+0.03), BONE: 4.28 (+0.20), RTIX: 3.64 (+0.03), IRMD: 7.24 (+0.06)
Mazor Robotics (MZOR) Jumps: Stock Moves 6.6% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Sep 04, 8:25AM CDT
Mazor Robotics (MZOR) was a big mover last session, with shares rising nearly 7% on the day.
ECTE: 0.74 (+0.03), BONE: 4.28 (+0.20), RTIX: 3.64 (+0.03), MZOR: 11.20 (-0.40)
The Zacks Analyst Blog Highlights: Medtronic, Covidien, Bacterin International Holdings, Inogen and Echo Therapeutics
PR Newswire - Wed Sep 03, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Medtronic Inc. (NYSE:MDT-Free Report), Covidien plc (NYSE:COV-Free Report), Bacterin International Holdings, Inc. (AMEX:BONE-Free Report), Inogen, Inc. (Nasdaq:INGN-Free Report) and Echo Therapeutics, Inc. (Nasdaq:ECTE-Free Report).
ECTE: 0.74 (+0.03), BONE: 4.28 (+0.20), MDT: 64.98 (+1.14), INGN: 19.72 (+0.04)
3 Top-Ranked Medical Equipment Stocks to Buy Now - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 02, 1:08PM CDT
The fiscal 2015 budget for the Department of Health and Human Services (HHS) has brought a fresh lease on life to the U.S. healthcare economy, following the past years' debacle.
ECTE: 0.74 (+0.03), ZMH: 101.32 (+2.13), BSX: 12.03 (+0.42), BONE: 4.28 (+0.20), MDT: 64.98 (+1.14), COV: 89.25 (+3.81), DGX: 61.12 (+1.47), INGN: 19.72 (+0.04), STJ: 59.99 (+1.03), LH: 101.30 (+2.36), SYK: 82.14 (+1.14)
Platinum Comments On Recent Statements Purportedly Made By Echo Therapeutics
PR Newswire - Mon Oct 06, 8:26AM CDT
An affiliate of Platinum Management (NY) LLC ("Platinum"
, the largest stockholder of Echo Therapeutics, Inc. ("Echo" or the "Company" (NASDAQ: ECTE) owning approximately 30% of Echo's outstanding Common Stock on a fully converted basis, today commented on recent statements made, Platinum can only assume, by William Grieco, Vincent Enright and James Smith (the "Lingering Directors" , purportedly on behalf of Echo. ECTE: 0.74 (+0.03)
Echo Therapeutics Comments On Special Meeting Proxy Contest Threatened By Platinum Management (NY) LLC
PR Newswire - Mon Oct 06, 8:10AM CDT
Echo Therapeutics, Inc. (NASDAQ: ECTE), a medical device company, today commented on the special meeting proxy contest that has been recently threatened by Platinum Management (NY) LLC and its affiliates in their latest attempt to force off the Echo Board the only independent board members that were not designated or nominated by Platinum.
ECTE: 0.74 (+0.03)
Echo Therapeutics Engages PricewaterhouseCoopers' Restructuring Practice to Explore Financial and Strategic Alternatives
PR Newswire - Thu Oct 02, 3:59PM CDT
Echo Therapeutics, Inc. (NASDAQ: ECTE), a medical device company, today announced that the Company has retained PricewaterhouseCoopers LLP's Restructuring and Recovery Services Practice (PwC) as a financial and restructuring consultant to assist the Company in exploring financial and strategic alternatives that could sufficiently address its liquidity needs and allow it to resume operations. Such financial and strategic alternatives could include, but are not limited to, a sale of intellectual property and other assets, a merger, other business combination, a capital transaction and/or a voluntary petition for reorganization or liquidation pursuant to the U.S. Bankruptcy Code.
ECTE: 0.74 (+0.03)
Echo Therapeutics Comments On Unauthorized Public Statements By Michael M. Goldberg, M.D. And Shepard M. Goldberg
PR Newswire - Thu Oct 02, 6:50AM CDT
Echo Therapeutics, Inc. (NASDAQ: ECTE), a medical device company, today commented on the recent unauthorized public statements relating to Echo that have been made by Michael Goldberg M.D. and Shepard M. Goldberg, two members of the Echo Board of Directors that were either designated or nominated to the Echo Board by an affiliate of Platinum Management (NY) LLC. In recent weeks, the Goldbergs have engaged in numerous unauthorized public communications targeted at Echo stockholders, the trading markets and the media. These have included an unauthorized public "investor" conference call during which the Goldbergs made a presentation relating to Echo, unauthorized press releases discussing Echo and other unauthorized statements by which the Goldbergs have sought to relay to Echo stockholders information relating to Echo, its prospects and its financing and strategic alternatives.
ECTE: 0.74 (+0.03)
Echo Therapeutics Suspends Operations on Cash Concerns - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 29, 4:45PM CDT
Following the company's decision, shares of Echo Therapeutics, Inc. (ECTE) crashed a substantial 32.5% to finally close at $0.77 till the last trading session.
ECTE: 0.74 (+0.03), ATEC: 1.49 (unch), EW: 105.81 (+3.94), ERB: 2.76 (-0.01)
Platinum Management (NY) LLC Calls for a Special Meeting of Stockholders at Echo Therapeutics, Inc.
PR Newswire - Mon Sep 29, 2:49PM CDT
Platinum Management (NY) LLC ("Platinum"
, the largest stockholder of Echo Therapeutics, Inc. ("Echo" or the "Company" (NASDAQ: ECTE) together with its affiliates owning approximately 30% of Echo's outstanding Common Stock on a fully converted basis, today announced that it intends to file the documents required to demand a Special Meeting of stockholders of Echo to remove, for cause, Directors William Grieco, Vincent Enright and James Smith. (collectively, the "Lingering Directors" ECTE: 0.74 (+0.03)
Platinum Management and Newly Elected Board Members Unveil New Financing Plan for Echo Therapeutics
GlobeNewswire - Wed Sep 24, 8:21AM CDT
Michael Goldberg M.D. and Shepard M. Goldberg, both recently elected board members of Echo Therapeutics (Nasdaq:ECTE), have expressed alarm at the press release issued by the Company yesterday evening, September 23. Dr. Goldberg and Mr. Goldberg believe the release, which they had not seen prior to its publication, contains numerous errors, misstatements and is not an accurate reflection of the current state of affairs at Echo Therapeutics. In fact, Dr. Goldberg and Mr. Goldberg, in an effort to salvage the company, have negotiated a financing deal that meets and exceeds the terms stated as necessary in the release issued by the opposing members of Echo's board. The proposed plan will allow Echo to continue operations and to reach key valuation events prior to requiring additional capital. The plan set forth by Dr. and Mr. Goldberg has the added benefit of having the support of Echo's former key technical staff members who were terminated yesterday but who remain committed to the company.
ECTE: 0.74 (+0.03)
Market Maker Surveillance Report. RITT, JRJC, UQM, GLMD, SINO, ECTE, Winning Stocks With Lowest Price Friction For Tuesday, September 23rd 2014
M2 - Wed Sep 24, 3:42AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 4582 companies with "abnormal" market making, 1424 companies with positive Friction Factors and 3854 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Tuesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Rit Technologies Ltd (NASDAQ:RITT), China Finance Online Co Ltd (NASDAQ:JRJC), UQM Technologies Inc (NYSE:UQM), GOLD MEDAL RES LTD (NASDAQ:GLMD), Sino-Global Shipping America Ltd (NASDAQ:SINO), Echo Therapeutics Inc (NASDAQ:ECTE). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
ECTE: 0.74 (+0.03), JRJC: 5.45 (+0.08), GLMD: 6.49 (-0.27), UQM: 1.09 (+0.01), RITT: 1.21 (+0.06), SINO: 2.04 (+0.31)
Echo Therapeutics Suspends Operations To Conserve Liquidity
PR Newswire - Tue Sep 23, 5:40PM CDT
Echo Therapeutics, Inc. (NASDAQ: ECTE), a medical device company, today announced that, as it believes that its current liquidity is insufficient to fund its needs beyond September 30, 2014, it has suspended its product development, research, manufacturing and clinical programs and operations to conserve its liquidity and capital resources.
ECTE: 0.74 (+0.03)
Market Maker Surveillance Report. CNQR, CNET, MGPI, INUV, ECTE, DSLV, Winning Stocks With Lowest Price Friction For Friday, September 19th 2014
M2 - Mon Sep 22, 3:07AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Friday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Friday there were 4914 companies with "abnormal" market making, 1880 companies with positive Friction Factors and 3143 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Friday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Concur Technologies Inc (NASDAQ:CNQR), Chinanet Online Holdings Inc (NASDAQ:CNET), MGP Ingredients Inc (NASDAQ:MGPI), Inuvo Inc (NYSE:INUV), Echo Therapeutics Inc (NASDAQ:ECTE), (NYSE
SLV). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net . ECTE: 0.74 (+0.03), CNQR: 127.86 (+0.02), INUV: 1.39 (+0.12), MGPI: 12.24 (+0.24), DSLV: 62.04 (-0.80), CNET: 2.05 (+0.22)
Newly Elected Board Members of Echo Therapeutics to Host Conference Call to Provide Shareholder Update on Monday, September 22nd
GlobeNewswire - Fri Sep 19, 3:25PM CDT
Michael Goldberg M.D. and Shepard M. Goldberg, both recently elected board members of Echo Therapeutics (Nasdaq:ECTE), will host a conference call with investors to discuss recent developments and also their goals to establish a new strategic direction for the company which will require the removal of the three predecessor directors for cause. In light of recent events at Echo Therapeutics, Dr. Goldberg and Mr. Goldberg have been contacted by a number of shareholders regarding their concerns about the stock price and lack of information from the current management team.
ECTE: 0.74 (+0.03)
Platinum to refund USD5m investment in Echo Therapeutics
M2 - Thu Sep 18, 7:15AM CDT
Platinum Wednesday disclosed its intention on Wednesday to seek the return of its USD5m investment in Echo in connection with the 10 December 2013 Securities Purchase Agreement.
ECTE: 0.74 (+0.03)
Platinum Seeks Return Of $5 Million Investment In Echo Therapeutics
PR Newswire - Wed Sep 17, 4:07PM CDT
Platinum Management (NY) LLC ("Platinum"
, the largest stockholder of Echo Therapeutics, Inc. ("Echo" or the "Company" (NASDAQ: ECTE) together with its affiliates owning approximately 30% of Echo's outstanding Common Stock on a fully converted basis, today delivered a letter to the members of the Echo Board of Directors disclosing its intention to seek the return of their $5 million investment in Echo in connection with the December 10, 2013 Securities Purchase Agreement. Platinum believes that Echo entered into the contract in bad faith with no intention of performing its obligations or using the funds for the intended purposes. Investors wishing to read the full letter are welcome to review Platinum's 13D, which attaches the full letter as an exhibit. Platinum's 13D may be found here: http://www.sec.gov/Archives/edgar/data/103192...091714.htm ECTE: 0.74 (+0.03)
Alphatec Holdings (ATEC) Worth Watching: Stock Adds 7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Sep 17, 8:46AM CDT
Alphatec Holdings (ATEC) was a big mover last session, with shares rising just over 7% on the day.
ECTE: 0.74 (+0.03), ATEC: 1.49 (unch), BONE: 4.28 (+0.20), RTIX: 3.64 (+0.03)
Sunshine Heart (SSH) Worth Watching: Stock Gains 8.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Sep 17, 8:25AM CDT
Sunshine Heart (SSH) was a big mover last session, with shares rising over 8% on the day.
ECTE: 0.74 (+0.03), SSH: 5.29 (+0.03), BONE: 4.28 (+0.20), RTIX: 3.64 (+0.03)
Echo Therapeutics Board Once Again Impedes The Rights Of Echo Stockholders
PR Newswire - Fri Sep 12, 4:53PM CDT
An affiliate of Platinum Management (NY) LLC ("Platinum"
, the largest stockholder of Echo Therapeutics, Inc. ("Echo" or the "Company" (NASDAQ: ECTE) owning approximately 30% of Echo's outstanding Common Stock on a fully converted basis, today filed suit in Delaware following the refusal by Echo to provide documents in response to Platinum's demand for certain books and records of the Company under Section 220 of the Delaware General Corporation Law. Platinum had previously delivered a letter to Echo pursuant to Section 220 demanding to inspect books and records relating to possible mismanagement, breaches of fiduciary duty and wrongdoing by, among others, members of the Board and the Company's current interim CEO, Kimberly A. Burke. ECTE: 0.74 (+0.03)
IRadimed (IRMD) Jumps: Stock Moves 7.4% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Sep 05, 8:25AM CDT
IRadimed (IRMD) was a big mover last session, with shares rising over 7% on the day.
ECTE: 0.74 (+0.03), BONE: 4.28 (+0.20), RTIX: 3.64 (+0.03), IRMD: 7.24 (+0.06)
Mazor Robotics (MZOR) Jumps: Stock Moves 6.6% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Sep 04, 8:25AM CDT
Mazor Robotics (MZOR) was a big mover last session, with shares rising nearly 7% on the day.
ECTE: 0.74 (+0.03), BONE: 4.28 (+0.20), RTIX: 3.64 (+0.03), MZOR: 11.20 (-0.40)
The Zacks Analyst Blog Highlights: Medtronic, Covidien, Bacterin International Holdings, Inogen and Echo Therapeutics
PR Newswire - Wed Sep 03, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Medtronic Inc. (NYSE:MDT-Free Report), Covidien plc (NYSE:COV-Free Report), Bacterin International Holdings, Inc. (AMEX:BONE-Free Report), Inogen, Inc. (Nasdaq:INGN-Free Report) and Echo Therapeutics, Inc. (Nasdaq:ECTE-Free Report).
ECTE: 0.74 (+0.03), BONE: 4.28 (+0.20), MDT: 64.98 (+1.14), INGN: 19.72 (+0.04)
3 Top-Ranked Medical Equipment Stocks to Buy Now - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 02, 1:08PM CDT
The fiscal 2015 budget for the Department of Health and Human Services (HHS) has brought a fresh lease on life to the U.S. healthcare economy, following the past years' debacle.
ECTE: 0.74 (+0.03), ZMH: 101.32 (+2.13), BSX: 12.03 (+0.42), BONE: 4.28 (+0.20), MDT: 64.98 (+1.14), COV: 89.25 (+3.81), DGX: 61.12 (+1.47), INGN: 19.72 (+0.04), STJ: 59.99 (+1.03), LH: 101.30 (+2.36), SYK: 82.14 (+1.14)
